{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:45:47Z","timestamp":1770885947227,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008303","name":"Department for Employment and Learning, Northern Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008303","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bcp.2012.10.008","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T18:06:35Z","timestamp":1350497195000},"page":"81-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob\/ob mice"],"prefix":"10.1016","volume":"85","author":[{"given":"Nigel","family":"Irwin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Charlotte","family":"Moffett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2012.10.008_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/j.1467-789X.2012.01017.x","article-title":"Obesity and socioeconomic status in developing countries: a systematic review","author":"Dinsa","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.bcp.2012.10.008_bib0010","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11695-012-0663-7","article-title":"Systematic review of obesity surgery mortality risk score-preoperative risk stratification in bariatric surgery","volume":"22","author":"Thomas","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/j.bcp.2012.10.008_bib0015","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1007\/s00125-012-2654-6","article-title":"Beneficial effects of the novel choleycystokinin agonist (pGlu-Gln)-CCK-8 in animal models of obesity-diabetes","volume":"55","author":"Irwin","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2012.10.008_bib0020","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2174\/156802607780960483","article-title":"The biology of cholecystokinin and gastrin peptides","volume":"7","author":"Rehfeld","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bcp.2012.10.008_bib0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/bjp.2008.257","article-title":"PEGylated cholecystokinin is more potent in inducing anorexia than conditioned taste aversion in rats","volume":"155","author":"Verbaeys","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2012.10.008_bib0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1152\/ajplegacy.1928.86.3.599","article-title":"A hormone mechanism for gallbladder contraction and evacuation","volume":"65","author":"Ivy","year":"1928","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bcp.2012.10.008_bib0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1748-1716.2010.02235.x","article-title":"Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides","volume":"201","author":"Rehfeld","year":"2011","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.bcp.2012.10.008_bib0040","doi-asserted-by":"crossref","first-page":"11707","DOI":"10.1074\/jbc.M110.198945","article-title":"Synergistic interaction between leptin and cholecystokinin in the rat nodose ganglia is mediated by PI3K and STAT3 signaling pathways: implications for leptin as a regulator of short term satiety","volume":"286","author":"Heldsinger","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.10.008_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0168-8227(91)90059-M","article-title":"Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man","volume":"13","author":"Ahr\u00e9n","year":"1991","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.bcp.2012.10.008_bib0050","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1210\/en.2010-0233","article-title":"Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival","volume":"151","author":"Lavine","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2012.10.008_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.beem.2009.03.011","article-title":"The spectrum of antidiabetic actions of GLP-1 in patients with diabetes","volume":"23","author":"Vilsb\u00f8ll","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.bcp.2012.10.008_bib0060","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/diabetes.47.10.1619","article-title":"Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation","volume":"47","author":"O\u2019Harte","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2012.10.008_bib0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0196-9781(96)00036-8","article-title":"The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A","volume":"17","author":"Migaud","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2012.10.008_bib0070","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bcp.2009.05.037","article-title":"Fatty acid derivatised analogs of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties","volume":"78","author":"Kerr","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2012.10.008_bib0075","first-page":"11","article-title":"Influence of genetic background and age on the expression of the obese hyperglycemic syndrome in Aston ob\/ob mice","volume":"6","author":"Bailey","year":"1982","journal-title":"Int J Obes"},{"key":"10.1016\/j.bcp.2012.10.008_bib0080","first-page":"36","article-title":"Image processing with image","volume":"11","author":"Abramoff","year":"2004","journal-title":"J Biophotonics International"},{"key":"10.1016\/j.bcp.2012.10.008_bib0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","article-title":"Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice","volume":"20","author":"Flatt","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2012.10.008_bib0090","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1463-1326.2010.01228.x","article-title":"Active immunization against (Pro3)GIP improves metabolic status in high-fat-fed mice","volume":"12","author":"Montgomery","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bcp.2012.10.008_bib0095","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bjp.2008.317","article-title":"(Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy","volume":"155","author":"McClean","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2012.10.008_bib0100","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1053\/j.gastro.2010.01.044","article-title":"Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity","volume":"138","author":"Lo","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2012.10.008_bib0105","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1073\/pnas.94.19.10455","article-title":"Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice","volume":"94","author":"Barrachina","year":"1997","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2012.10.008_bib0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0031-9384(78)90278-0","article-title":"Inconsistency and possible habituation of CCK-induced satiety","volume":"21","author":"Mineka","year":"1978","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bcp.2012.10.008_bib0115","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/302703a0","article-title":"Rapid development of tolerance to the behavioural actions of cholecystokinin","volume":"302","author":"Crawley","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2012.10.008_bib0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.peptides.2008.11.010","article-title":"Lack of tolerance development with long-term administration of PEGylated cholecystokinin","volume":"30","author":"Verbaeys","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.bcp.2012.10.008_bib0125","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.2337\/db10-0789","article-title":"Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice","volume":"60","author":"Lo","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2012.10.008_bib0130","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1113\/jphysiol.2009.169078","article-title":"Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men","volume":"587","author":"Br\u00f8ns","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.bcp.2012.10.008_bib0135","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1210\/en.2011-2170","article-title":"Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry","volume":"153","author":"Habib","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2012.10.008_bib0140","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/db11-0489","article-title":"CCK stimulation of GLP-1 neurons involves \u03b11-adrenoceptor-mediated increase in glutamatergic synaptic inputs","volume":"60","author":"Hisadome","year":"2011","journal-title":"Diabetes"},{"issue":"S1","key":"10.1016\/j.bcp.2012.10.008_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1463-1326.2011.01441.x","article-title":"In vivo conversion of adult \u03b1-cells into \u03b2-like cells: a new research avenue in the context of type 1 diabetes","volume":"13","author":"Courtney","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bcp.2012.10.008_bib0150","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/endo.142.2.7983","article-title":"Minireview: the glucagon-like peptides","volume":"142","author":"Drucker","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2012.10.008_bib0155","first-page":"121","article-title":"Glucagon and glucagon-like peptides 1 and 2","volume":"50","author":"Holst","year":"2010","journal-title":"Results Probl Cell Differ"},{"key":"10.1016\/j.bcp.2012.10.008_bib0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/JOE-11-0094","article-title":"Processing of proglucagon to GLP-1 in pancreatic \u03b1-cells: is this a paracrine mechanism enabling GLP-1 to act on \u03b2-cells","volume":"211","author":"Whalley","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bcp.2012.10.008_bib0165","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.2337\/db07-0563","article-title":"A switch from prohormone convertase (PC)-2 to PC1\/3 expression in transplanted alpha-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in mice","volume":"56","author":"Wideman","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2012.10.008_bib0170","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/db09-0278","article-title":"Glucagon-like peptide 1\/glucagon receptor dual agonism reverses obesity in mice","volume":"58","author":"Pocai","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2012.10.008_bib0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/CBB:35:2:191","article-title":"Signal integration and the specificity of insulin action","volume":"35","author":"Kanzaki","year":"2001","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.bcp.2012.10.008_bib0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0195-6663(87)90021-3","article-title":"Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise","volume":"8","author":"West","year":"1987","journal-title":"Appetite"},{"key":"10.1016\/j.bcp.2012.10.008_bib0185","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.pharmtox.47.120505.105256","article-title":"The obesity epidemic: current and future pharmacological treatments","volume":"47","author":"Hofbauer","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212006806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212006806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:01:57Z","timestamp":1762095717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295212006806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0006295212006806"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2012.10.008","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob\/ob mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2012.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}